# Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study

> **NCT01287351** · — · COMPLETED · sponsor: **Research in Real-Life Ltd** · enrollment: 82903 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** extra-fine hydrofluoroalkane beclometasone dipropionate
- **DRUG:** Fluticasone propionate

## Key facts

- **NCT ID:** NCT01287351
- **Lead sponsor:** Research in Real-Life Ltd
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2008-12
- **Final completion:** 2010-10
- **Target enrollment:** 82903 (ACTUAL)
- **Last updated:** 2013-08-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01287351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01287351, "Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01287351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*